Haas Kevin Richard Insider Trades

Insider Trading History

Track insider trading activity for Haas Kevin Richard. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Veracyte
Veracyte VCYT
Chief Dev And Tech Officer
Holding Value $2.63M 44,221 shares
Last Trade
Apr 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.37M 44,221 shares
$31.09
$59.51
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.19M 188,404 shares
Last Trade
Mar 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$54.7k 11,737 shares
$4.66
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.21M 191,759 shares
Last Trade
Mar 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.4k 4,161 shares
$4.66
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.24M 195,920 shares
Last Trade
Mar 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29.9k 6,412 shares
$4.66
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.28M 202,332 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 23,697 shares
$5.47
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.14M 180,359 shares
Last Trade
Mar 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$29k 2,901 shares
$9.98
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.17M 186,029 shares
Last Trade
Mar 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.9k 6,187 shares
$10.01
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.18M 187,723 shares
Last Trade
Mar 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$33.6k 3,335 shares
$10.07
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.21M 191,058 shares
Last Trade
Mar 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$44.2k 4,390 shares
$10.07
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $1.23M 195,448 shares
Last Trade
Mar 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$525k 54,124 shares
$9.70
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $811k 128,566 shares
Last Trade
Feb 25, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.9k 1,016 shares
$11.74
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $892k 141,324 shares
Last Trade
Feb 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158k 12,758 shares
$12.41
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $818k 129,582 shares
Last Trade
Oct 09, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.3k 2,515 shares
$24.37
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $844k 133,815 shares
Last Trade
Mar 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$64.3k 2,890 shares
$22.24
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $852k 134,987 shares
Last Trade
Mar 22, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37.5k 1,685 shares
$22.24
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $862k 136,672 shares
Last Trade
Mar 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$70k 3,306 shares
$21.16
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $883k 139,978 shares
Last Trade
Mar 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$750k 35,178 shares
$21.32
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $661k 104,800 shares
Last Trade
Feb 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20k 881 shares
$22.72
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $667k 105,681 shares
Last Trade
Oct 09, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$25.7k 1,710 shares
$15.01
$6.31
Myriad Genetics
Myriad Genetics MYGN
Chief Technology Officer
Holding Value $678k 107,391 shares
Last Trade
Sep 26, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.7k 858 shares
$15.99
$6.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up